59 related articles for article (PubMed ID: 432131)
1. [Long-term survival of patients with Hodgkin's disease].
Kardaszewicz S; Japa J; Luciak M; Rozek-Lesiak K; Rusinowska Z; Urgacz-Ficek J
Pol Tyg Lek; 1979 Jan; 34(5):173-5. PubMed ID: 432131
[No Abstract] [Full Text] [Related]
2. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
3. [Long-term survival after 1 or more recurrences of Hodgkin's lymphomas].
Stamenkovic I; Alberto P; Mermillod B
Schweiz Med Wochenschr; 1982 Dec; 112(49):1805-7. PubMed ID: 7178880
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
[TBL] [Abstract][Full Text] [Related]
5. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
6. [Effect of various factors on the survival period in Hodgkin's disease].
Gabryś K; Sciborski R; Gałazka Z; Smakowska E; Kotlarek-Haus S
Pol Tyg Lek; 1982 Jul; 37(24-25):713-5. PubMed ID: 7177968
[No Abstract] [Full Text] [Related]
7. Outcome in Hodgkin's disease: a 20-year cohort of patients.
Ranaghan L; Markey GM; Morris TC
Ulster Med J; 1998 Nov; 67(2):91-8. PubMed ID: 9885544
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's disease and leukemia.
Stat Bull Metropol Life Insur Co; 1981; 62(4):2-4. PubMed ID: 7347039
[No Abstract] [Full Text] [Related]
9. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
Sampi K; Maseki N; Sakurai M; Hattori M
Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
[No Abstract] [Full Text] [Related]
10. What is the price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients.
Zsófia M; Katalin K; Judit V; György S; Arpád I
Hematol Oncol; 2007 Dec; 25(4):178-83. PubMed ID: 17607807
[TBL] [Abstract][Full Text] [Related]
11. [Factors influencing the long term survival of patients suffering from Hodgkin's disease].
Jelliffe AM
Nouv Rev Fr Hematol; 1966; 6(1):85-93. PubMed ID: 4222313
[No Abstract] [Full Text] [Related]
12. Long-term (15 years) results of extended field radiotherapy in Hodgkin's disease.
Sevcíková EL; Boljesíková E; Chorváth M; Kovacicová G
Neoplasma; 2000; 47(4):253-6. PubMed ID: 11043832
[TBL] [Abstract][Full Text] [Related]
13. [Long-term (over 10-years) survival in Hodgkin's disease].
Kotlarek-Haus S; Gabryś K; Kuliszkiewicz-Janus M; Potoczek S; Kiełbiński M
Acta Haematol Pol; 1993; 24(1):35-42. PubMed ID: 8488735
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics of patients with Hodgkin's disease treated at the Institute of Oncology at Gliwice in the years 1947-1962].
Slomska J; Rattka P
Pol Tyg Lek; 1970 Aug; 25(32):1210-2. PubMed ID: 5472550
[No Abstract] [Full Text] [Related]
15. Statistical procedures for evaluating survival in Hodgkin's disease.
Myers MH; Axtell LM
Natl Cancer Inst Monogr; 1973 May; 36():555-9. PubMed ID: 4800297
[No Abstract] [Full Text] [Related]
16. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
18. [Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality].
Huang HQ; Jiang WQ; Wang W; Xu GC; Zhang L; He YJ; Sun XF; Zhou ZM; Liu DG; Xu RH; Lin TY; Teng XY; Liu MZ; Su YS; Li YH; Lin XB; Guan ZZ
Ai Zheng; 2002 Dec; 21(12):1345-9. PubMed ID: 12520745
[TBL] [Abstract][Full Text] [Related]
19. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Hodgkin's disease at a local hospital.
Aghai E; Quitt M; Kuten A; Froom P
Isr J Med Sci; 1995; 31(2-3):176-8. PubMed ID: 7744590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
